Reducing aggression in military personnel: a randomized clinical trial

The Defense Health Agency (DHA) awarded Tampa VA Research and Education Foundation, Inc. a $639,831 project grant under the Military Medical Research and Development program (CFDA 12.420) effective September 30, 2025, through September 29, 2029. The grant supports a randomized clinical trial focused on reducing aggression in military personnel. The research will be conducted at the foundation's facility in Temple Terrace, Florida, and represents part of the DHA's broader portfolio of hypothesis-driven biomedical research initiatives designed to transform healthcare for military service members through innovative medical solutions addressing critical health challenges.

As a research-oriented, non-profit organization with established expertise in veterans' health and military medical research, Tampa VA Research and Education Foundation will execute the clinical trial investigation, which aligns with the Military Medical Research and Development program's emphasis on translational research and clinical trial execution. The foundation's track record of collaboration with federal agencies and academic institutions positions it to deliver rigorous scientific outcomes that advance knowledge in military mental health and behavioral health interventions. Award performance is anticipated over a typical four-year period consistent with program standards.